Revenue
attach_money3M EUR
YoY -77.9%
IPHAInnate Pharma S.A.$ --
Innate Pharma S.A.
IPHA
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-53M EUR
YoY -3.6%
Net Income
verified-47M EUR
YoY +4.5%
EPS
pie_chart-0.53EUR
YoY +13.1%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress110.9%On Track
Revenue Progress2.8M
Revenue Forecast14.7M
Net Income Progress-49M
Net Income Forecast-44.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.